2011
DOI: 10.1007/s12272-011-1000-8
|View full text |Cite
|
Sign up to set email alerts
|

Enriching modern pharmacotherapy through synergy assessment for the combination of natural products and synthetic drugs

Abstract: 5-O-methylglovanon (5-O-MG) is a bioactive compound first isolated and characterized from Glycosmis plants. In this issue, Zhou et al. evaluated the anti-staphylococcal effects of 5-O-MG against ampicillin-resistant isolates of Staphylococcus aureus and S. epidermidis. The authors showed that the combination of 5-O-MG and ampicillin significantly increased the susceptibility of Staphylococcus strains to the drugs by decreasing MICs with a comparable anti-staphylococcal effect to that of β-lactamase inhibitors,… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 12 publications
0
4
0
Order By: Relevance
“…Pathogens such as vancomycin-resistant Enterococcus faecium and multidrug-resistant Staphylococcus aureus , which are on the CDC’s list of serious threats, could jeopardize health care systems because there are limited defenses against them , and there is a potential of transferring chemical resistance to more dangerous pathogens . Combinatorial treatments that target multiple bacterial pathways or enhance drug activity are currently used, for example the coadministration of amoxicillin and clavulanic acid to treat β-lactamase-producing S. aureus and, despite some controversy, combinations of vancomycin with β-lactams or daptomycin as a last resort therapy. Finding compounds that act in synergistic ways might improve our chances of fighting AR and, in turn, our ability to combat infectious diseases.…”
mentioning
confidence: 99%
“…Pathogens such as vancomycin-resistant Enterococcus faecium and multidrug-resistant Staphylococcus aureus , which are on the CDC’s list of serious threats, could jeopardize health care systems because there are limited defenses against them , and there is a potential of transferring chemical resistance to more dangerous pathogens . Combinatorial treatments that target multiple bacterial pathways or enhance drug activity are currently used, for example the coadministration of amoxicillin and clavulanic acid to treat β-lactamase-producing S. aureus and, despite some controversy, combinations of vancomycin with β-lactams or daptomycin as a last resort therapy. Finding compounds that act in synergistic ways might improve our chances of fighting AR and, in turn, our ability to combat infectious diseases.…”
mentioning
confidence: 99%
“…5-O-methylglovanon isolated from Glycosmis plants is an isoprenyl flavonoid compound with broad-spectrum antibacterial activity. The compound can lower the production of β-lactamases to facilitate the action of ampicillin in S. epidermidis and S. aureus [203].…”
Section: Plant-derived Synergists As Inhibitors Of Antibiotic Degradi...mentioning
confidence: 99%
“…[88,89] These natural products are isolated through a bioactivity-guided fractionation of the total plant extract. [88,89] These natural products are isolated through a bioactivity-guided fractionation of the total plant extract.…”
Section: Dgat Inhibitors Of Plant Originmentioning
confidence: 99%
“…Plants have always been a rich source for drug screening, either alone or in combination with existing drugs. [88,89] These natural products are isolated through a bioactivity-guided fractionation of the total plant extract. Traditional oriental medicine is mainly plant-based, and the isolation and structural determination of the products used has mostly been carried out in Asia.…”
Section: Dgat Inhibitors Of Plant Originmentioning
confidence: 99%